There is no guarantee of purity, accurate dosing, or the absence of contaminants
Many of these substances were designated as Category 2 substances on the FDAs interim 503A Bulks List in 2023, reflecting the FDAs preliminary determination that they presented significant safety risks in the context of compounding
Published studies have investigated GHK-Cu in tissue remodelling, skin physiology, wound healing, connective tissue biology, angiogenesis, inflammatory signalling, hair biology and regenerative medicine
Vitamin B12 Injection Information medically reviewed by Carol Hou (BSc
4c), an observation that is in agreement with our biochemical analyses (Table 1)